Atypical antidepressant linked to severe adverse effects and death as a result of misuse.
Citing Severe Health Risks, FDA Issues Warning Against Using Tianeptine Products
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours